MRM
MEDIROM Healthcare Technologies Inc.NASDAQConsumer Cyclical$1.13+0.89%ClosedMarket Cap: $5.8M
As of 2026-04-06
Valuation
P/E (TTM)
0.01
PEG
0.00
P/B
2.83
P/S
0.00
EV/EBITDA
0.04
DCF Value
$64.37
FCF Yield
-19482.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
34.5%
Operating Margin
12.6%
Net Margin
15.0%
ROE
155.1%
ROA
1312.1%
ROIC
1751.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $21.9M | 10.8% | $-5.6M | $-4.7M | $-0.59 | — |
| Q4 2024 | $4.82B | 34.6% | $618.6M | $730.9M | $118.73 | — |
| FY 2024 | $8.30B | 27.1% | $-18.1M | $148.8M | $28.52 | — |
| Q2 2024 | $3.48B | 16.6% | $-636.7M | $-582.2M | $-118.56 | — |
| Q4 2023 | $3.59B | 24.8% | $-81.3M | $470.5M | $86.32 | — |
| FY 2023 | $6.83B | 23.0% | $-391.6M | $115.0M | $22.27 | — |
| Q2 2023 | $3.24B | 20.9% | $-310.3M | $-355.1M | $-72.72 | — |
| Q4 2022 | $3.81B | 28.5% | $251.8M | $330.5M | $54.54 | — |
| FY 2022 | $6.95B | 27.4% | $97.0M | $149.0M | $27.23 | — |
| Q2 2022 | $1.57B | 25.9% | $-76.9M | $-90.8M | $-18.59 | — |
| Q4 2021 | $1.64B | 32.2% | $43.4M | $-234.5M | $-48.03 | — |
| FY 2021 | $5.41B | 26.2% | $-470.6M | $-990.7M | $-203.13 | — |